Valerio Therapeutics Société anonyme (EPA:ALVIO)
0.1475
-0.0020 (-1.34%)
At close: Feb 20, 2026
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €72.11 million as of February 20, 2026. Its market cap has increased by 764.02% in one year.
Market Cap
72.11M
Enterprise Value
92.96M
Revenue
1.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.15
Market Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has decreased from 72.77M to 72.11M, a decrease of -0.91%. That is a compound annual growth rate of -0.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 72.11M | 6.88% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transgene | 221.80M |
| MaaT Pharma | 143.76M |
| Innate Pharma | 136.05M |
| Adocia | 134.21M |
| ABIONYX Pharma | 122.77M |
| OSE Immunotherapeutics | 98.11M |
| Sensorion | 91.91M |
| THX Pharma Société Anonyme | 45.67M |